<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05100615</url>
  </required_header>
  <id_info>
    <org_study_id>238</org_study_id>
    <nct_id>NCT05100615</nct_id>
  </id_info>
  <brief_title>Healing Assessment of Osseous Defects After Surgical Removal of Periapical Lesions</brief_title>
  <official_title>Healing Assessment of Osseous Defects After Surgical Removal of Periapical Lesions in the Presence of Hydroxyapatite, Nanohydroxyapatite and Combination of Nanohydroxyapatite and Platelet-rich Fibrin. A Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Minia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Minia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      recruited patients with periapical lesions will be divided into three groups and surgically&#xD;
      treated with three types of bone graft (hydroxyappatite, nanohydroxyappatite and PRF WITH&#xD;
      NANOHYDROXTAPPATITE) and then evaluated for month, three months and six months for the&#xD;
      healing of periapical bone&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">May 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>healing of periapical lesion</measure>
    <time_frame>interappointment at 1 month, 3 months and 6 months</time_frame>
    <description>change in size of bony defect</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Effects of the Elements</condition>
  <arm_group>
    <arm_group_label>hydroxyappatite</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>hydroxyapatite powder used for enhancement of bone regeneration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>nanohydroxyapatite</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>nanohydroxyapatite powder used for enhancement of bone regeneration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PRF with nanohydroxyapatite</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>platelet rich fibrin mixed with nanohydroxyapatite used for enhancement of bone regeneration</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>surgery</intervention_name>
    <description>applying the graft inside bony defect after surgery</description>
    <arm_group_label>PRF with nanohydroxyapatite</arm_group_label>
    <arm_group_label>hydroxyappatite</arm_group_label>
    <arm_group_label>nanohydroxyapatite</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patient will be in range of 20-45 years of age at the time of treatment, having&#xD;
             periapical lesions starting from 5mm or more in diameter related to failed&#xD;
             endodontically treated single canaled teeth.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any systemic debilitating disease such as:&#xD;
&#xD;
        Diabetes mellitus, renal disease, Liver disease or liver failure, Rheumatoid arthritis,&#xD;
        Neoplastic disease or its treatment, chronic corticosteroid therapy, chronic hepatitis B or&#xD;
        C , History of hepatitis A, pregnant females.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Amira Elkholly, PHD</last_name>
    <phone>+201001902507</phone>
    <phone_ext>Egypt</phone_ext>
    <email>dr.amiraelkholly@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Reham Hassan, Ass.prof</last_name>
    <phone>+201001542529</phone>
    <phone_ext>Egypt</phone_ext>
    <email>reham-hassan@live.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Amira mohammed fathy Elkholly</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amira Elkholly, PHD</last_name>
      <phone>01001902507</phone>
      <email>dr.amiraelkholly@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Reham Hassan, Ass.prof</last_name>
      <phone>01001542529</phone>
      <email>reham-hassan@live.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 28, 2021</study_first_submitted>
  <study_first_submitted_qc>October 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2021</study_first_posted>
  <last_update_submitted>October 20, 2021</last_update_submitted>
  <last_update_submitted_qc>October 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Minia University</investigator_affiliation>
    <investigator_full_name>Amira mohammed elkholly</investigator_full_name>
    <investigator_title>phD student- Endodontic Departement</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

